Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana Linfomi.
Levis M, Campbell BA, Matrone F, Grapulin L, Di Russo A, Buglione M, Iamundo De Cumis I, Simontacchi G, Ciammella P, Magli A, Pascale G, Meregalli S, MacManus M, Fanetti G, De Felice F, Furfaro G, Ciccone G, Ricardi U. Levis M, et al. Among authors: di russo a. Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1008-1018. doi: 10.1016/j.ijrobp.2023.02.019. Epub 2023 Feb 21. Int J Radiat Oncol Biol Phys. 2023. PMID: 36822373
Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients.
Lucchini E, Rusconi C, Levis M, Ricci F, Santoro A, Ricardi U, Volpetti S, Matrone F, di Russo A, Caizzi M, Schiattarella A, Zaja F. Lucchini E, et al. Among authors: di russo a. Hematol Rep. 2021 Jun 9;13(2):9080. doi: 10.4081/hr.2021.9080. eCollection 2021 Jun 9. Hematol Rep. 2021. PMID: 34221295 Free PMC article.
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.
Filippi AR, Meregalli S, DI Russo A, Levis M, Ciammella P, Buglione M, Guerini AE, De Marco G, De Sanctis V, Vagge S, Ricardi U, Simontacchi G; Fondazione Italiana Linfomi (FIL) Radiotherapy Committee. Filippi AR, et al. Among authors: di russo a. Radiat Oncol. 2020 Mar 12;15(1):62. doi: 10.1186/s13014-020-01504-8. Radiat Oncol. 2020. PMID: 32164700 Free PMC article. Review.
Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Ruella M, Filippi AR, Bruna R, Di Russo A, Magni M, Caracciolo D, Passera R, Matteucci P, Di Nicola M, Corradini P, Parvis G, Gini G, Olivieri A, Ladetto M, Ricardi U, Tarella C, Devizzi L. Ruella M, et al. Among authors: di russo a. Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015 Dec 17. Int J Radiat Oncol Biol Phys. 2016. PMID: 26972651
25 results